Other languages Duality S.A.

Equities

DUA

PLDLITY00010

End-of-day quote Warsaw S.E. Other stock markets 06:00:00 2024-05-30 pm EDT			5-day change	1st Jan Change
1.615 ^PLN	+1.25%		+0.31%	+9.12%

May. 15	Duality S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 20	Duality S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Duality S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 15
Duality S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 20
BioNTech to Present Clinical Data Updates on Cancer Vaccine Candidates	Mar. 11
Tod's CEO says he has no plans to sell 'family business'	Feb. 23
BioNTech, Duality Biologics Obtain FDA Fast Track Designation for Ovarian Cancer Therapy Candidate	Jan. 31
BioNTech's Cancer Therapy Candidate Obtains Fast-track Designation from US FDA	Jan. 31
BioNTech, Duality Biologics Initiate Phase 3 Trial of Breast Cancer Drug	Jan. 22
BioNTech Begins Late-stage Study for Metastatic Breast Cancer Therapy Candidate	Jan. 22
BioNTech challenges AstraZeneca with breast cancer precision drug trial	Jan. 22
BioNTech, Duality Biologics Get US FDA Breakthrough Therapy Designation for Uterine Cancer Drug Candidate	Dec. 21
Duality S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14
Australia's Albanese to highlight trade on China visit as ties warm	Nov. 03
Duality S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14
Introducing Janus, the exotic 'two-faced' white dwarf star	23-07-21
HBM Holdings, Beigene Sign License Deal for Antibody-Drug Conjugate Program; HBM Shares Soar 20%	23-07-14
Duality S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15
BioNTech, DualityBio Sign Strategic Partnership to Develop ADC Therapeutics to Treat Solid Tumors	23-04-03
BioNTech Partners With DualityBio to Develop Cancer Treatments	23-04-03
BioNTech, Duality Biologics Enter Licensing Agreement for Cancer Treatments	23-04-03
Credit Suisse on Hydro One: "All About Ontario with the Duality of Delivering Decarbonization and Defensive Growth"	23-03-31

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Duality S.A.

Equities

DUA

PLDLITY00010

Other languages

Filters